Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OvuSense is a women's health and fertility technology company best known for its OvuSense ovulation monitoring products and app-based cycle analytics. The company commercializes FDA-cleared fertility monitoring devices, including the OvuCore vaginal sensor and OvuFirst skin-worn sensor, which use continuous temperature measurements and proprietary algorithms to predict and confirm ovulation. Its products are positioned for pregnancy planning and cycle monitoring, particularly for women with irregular periods or PCOS. Historically the business has operated under the legal name Fertility Focus and later the name viO HealthTech. In August 2025, viO HealthTech, the maker of OvuSense, announced that it had been acquired by Ultrahuman, while continuing operations and customer support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OvuSense.